WHAT IS GENOMICS?
CRISPR’s next act: what epigenetic editing means for Australia’s genomics system
A Nature news feature has profiled a new wave of companies developing a different kind of gene therapy. Rather than cutting DNA, these therapies change the chemical markers that sit on it and switch genes on or off. The approach is called epigenetic editing. The...
Gene editing reaches younger children: the access question this raises for Australia
A new study in the New England Journal of Medicine reports promising results from a CRISPR gene-editing therapy in children aged 5 to 11. The children had severe sickle cell disease or transfusion-dependent beta thalassaemia, both inherited blood disorders. HCA...
Improving therapeutic recommendations on somatic NGS reports
InGeNA and HGSA are collaborating on a national project examining the presentation of therapeutic recommendations in somatic oncology next-generation sequencing reports. As precision oncology advances, clinicians need clear, accurate and current information to help...